FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Allows 1st Master File Use for Sterilizer

FDA accepts the first master file for participation in the 510(k) Ethylene Oxide Sterility Change Master File Pilot Program.

latest-news-card-1
FDA General

FDA WEBVIEW CLOSED JULY 4TH WEEK

In annual observance of the Fourth of July (Independence Day) holiday in the U.S., FDA Webview closes its news operations until Monday, July 10.

latest-news-card-1
Federal Register

Patient Guides for Orthopedic Implants

Federal Register notice: FDA announces the availability of the draft guidance entitled Patient-Matched Guides to Orthopedic Implants.

latest-news-card-1
Human Drugs

Rhinosinusitis Drug Development Guidance

FDA publishes a guidance to help in the development of drug and biological products to treat chronic rhinosinusitis with nasal polyps.

latest-news-card-1
Human Drugs

Compounding Inspection, Oversight FAQs

The FDA Compounding Quality Center of Excellence posts 14 questions and answers about compounding inspections and oversight.

latest-news-card-1
Human Drugs

FDA OKs 1st Diabetes Cellular Therapy

FDA approves CellTrans Lantidra, the first cellular therapy to treat some patients with Type 1 diabetes.

latest-news-card-1
Federal Register

Info Collection on Advisory Committee Regs

Federal Register notice: FDA sends an information collection revision to OMB entitled FDA Advisory Committee Regulations."

latest-news-card-1
Federal Register

Info Collection on Device Conformity Assessments

Federal Register notice: FDA sends to OMB an information collection revision entitled Accreditation Scheme for Conformity Assessment Program.

latest-news-card-1
Human Drugs

18-Page FDA-483 on Ipca Laboratories Inspection

FDA releases the form FDA-483 with 11 observations from an inspection at Indias Ipca Laboratories Ratlam API facility.

latest-news-card-1
Human Drugs

BioMarin Gene Therapy for Hemophilia A OKd

FDA approves a BioMarin Pharmaceutical BLA for Roctavian (valoctocogene roxaparvovec-rvox) gene therapy for treating adults with severe hemophilia A.